by Eric Christianson | Oct 6, 2024 | Clinical Pharmacy News and New Drug Updates, Women’s and Men’s Health Medication and Disease State Clinical Pearls
Fezolinetant (Veozah) is a central nervous system agent that works as an antagonist at the neurokinin 3 (NK3) receptor. This action inhibits neurokinin B (NKB) binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron which alters activity in the thermoregulatory...
